Free shipping over €200 | Certificate of Analysis included | ✉️ support@certapeptides.com | 💬 Live Chat
Research-grade compound. Laboratory use only. Not intended for human or animal use, ingestion, or injection. No medical claims are made or implied.

Delivers to EU in 7-10 business days
Free shipping over €200 · no customs paperwork (EU) · via EU carrier network
Research-grade BAM15 Capsule. 99.3% avg purity, HPLC & MS verified. Oral capsules in sealed bottle. For laboratory research use only. Not for human consumption.
MADE TO ORDER — Expected delivery: ~3 weeks
Synthesized after your order is placed. We'll email you tracking details when it ships.
This product is being restocked
We're working with our supplier to restock this item. Sign up below to be the first to know, or save it to your wishlist.
Important Notice
This product is intended for laboratory and research use only. Not for human or veterinary use. By purchasing, you confirm this product will be used exclusively for in-vitro research purposes.
99.3% average HPLC purity, verified by independent third-party testing
Janoshik report published when available
24h dispatch, EU-wide shipping from €4.99
Independent lab verification for every batch
BAM15 is a selective mitochondrial uncoupler -- a compound that dissipates the proton gradient across the inner mitochondrial membrane without affecting the plasma membrane potential. That selectivity is the key feature distinguishing it from older uncouplers. Classical compounds like DNP (2,4-dinitrophenol) and FCCP are effective but indiscriminate: they disrupt proton gradients across any phospholipid bilayer, including the plasma membrane. The consequences are dose-limiting toxicity including hyperthermia, cardiovascular instability, and cell death. BAM15's chemical structure selectively targets the mitochondrial inner membrane, producing controlled proton leak without off-target membrane depolarization.
The research value is in studying energy expenditure and metabolic flexibility. When the mitochondrial proton gradient is dissipated, cells must increase substrate oxidation to maintain ATP levels -- essentially burning more fuel. In preclinical models, BAM15 increases energy expenditure and modulates adipose tissue metabolism without the metabolic adaptation plateau or muscle catabolism associated with caloric restriction. For researchers studying thermogenesis, mitochondrial biology, or metabolic syndrome models, it provides a cleaner research tool than any previous uncoupler. Each capsule provides 50mg.
BAM15 is used in research on mitochondrial uncoupling mechanisms, thermogenesis and energy expenditure, adipose tissue biology, metabolic syndrome and obesity models, and as a cleaner alternative to FCCP or DNP in studies requiring controlled uncoupling without off-target toxicity.
| Parameter | Value |
|---|---|
| Active Ingredient | BAM15 (selective mitochondrial uncoupler) |
| Dose per Capsule | 50mg |
| Purity | 99.3% avg (HPLC verified) |
| Format | Oral capsule |
| Storage | Room temperature, protect from light and moisture |
Store at room temperature in a cool, dry place away from light. BAM15 is a small molecule with good ambient stability. Protect from moisture and direct light exposure.
BAM15 selectively targets the inner mitochondrial membrane rather than disrupting proton gradients across all biological membranes. DNP and FCCP are membrane-permeable across any lipid bilayer, which means they depolarize the plasma membrane at effective concentrations -- causing hyperthermia, cardiovascular toxicity, and cell death. BAM15's selectivity for the mitochondrial inner membrane allows controlled uncoupling of oxidative phosphorylation without these off-target effects. This makes it a more precise research tool for studying mitochondrial biology and energy metabolism.
When the mitochondrial proton gradient is dissipated, the cell must increase substrate oxidation (burning fuel) to maintain adequate ATP production. This increases basal metabolic rate and energy expenditure. In animal models, BAM15 administration increases whole-body energy expenditure, promotes fat oxidation, and reduces adiposity without the muscle catabolism or metabolic adaptation seen with caloric restriction. Brown adipose tissue naturally uses this mechanism via UCP1 protein for thermogenesis -- BAM15 provides a pharmacological tool to study controlled uncoupling in other tissue contexts.
The capsule format provides a pre-weighed dose (50mg) suitable for oral administration in animal model research. The powder format allows researchers more flexibility in dosing -- useful for preparing solutions for intraperitoneal injection or for custom doses. Chronic oral dosing studies generally benefit from the capsule format for consistency, while acute dose-ranging experiments or protocols requiring injection may prefer the powder form.
BAM15 Capsule is supplied for laboratory research use only. Not approved for human use. Handle in compliance with institutional biosafety guidelines.
Researcher Confidence
Who actually tests this?
Every batch is independently verified by Janoshik Analytical (100,000+ verifications/month), Eurofins Scientific, and Analytical Sciences International. We publish every Certificate of Analysis.
View COAs →What if I get the wrong batch?
Every bottle label carries a lot number that maps to a specific Certificate of Analysis. If a batch fails spec, we don't ship it — full stop.
View COAs →Where does it ship from?
Romania (EU). We are CERTALAB SRL, CUI RO54451735, VAT-registered. SameDay for Romania, FanCourier for Central/Eastern EU, TCE Worldwide for the rest. 3–7 business days EU-wide.
Shipping details →What if there's a problem?
You have a 14-day withdrawal right under OUG 34/2014 (Romanian/EU consumer law), with ANPC/ODR escalation available. Contact us at support@certapeptides.com.
Returns policy →This product is intended for scientific research and development purposes only. It is a chemical substance that shall not be used as a drug, medicine, active substance, or ingredient in any product intended for human or animal consumption. Researchers must handle this compound in accordance with their institutional biosafety guidelines. Use only in properly equipped laboratory settings with appropriate personal protective equipment.
500mcgSAME FIELDKPV is a naturally occurring tripeptide (Lys-Pro-Val) derived from the C-terminal end of alpha-melanocyte-stimulating hormone (alpha-MSH). It has been studied for its immunomodulatory signaling in gastrointestinal and immune biology research models. Alpha-MSH-derived immunomodulatory tripeptide Intestinal epithelial barrier and PepT1 transporter research NF-kB pathway modulation studies For research purposes only. Not for human consumption.
SAME FIELDOral Semaglutide capsules for research into GLP-1 receptor agonism via enteric delivery. Available in 3mg and 7mg formulations. Supplied at 99.3% avg purity (HPLC-verified), with a Certificate of Analysis for every batch. Key research areas: Oral peptide bioavailability and absorption kinetics GLP-1 receptor-mediated glucose homeostasis Enteric coating and SNAC co-formulation studies For research purposes only. Not for human consumption.
RESEARCHERS ALSO STUDIEDRetatrutide 10mg + Bacteriostatic Water 5ml + syringe + storage vial + alcohol pads. Everything you need to begin research. For research purposes only.
RESEARCHERS ALSO STUDIEDTirzepatide 10mg + Bacteriostatic Water 5ml + syringe + storage vial + alcohol pads. Everything you need to begin research. For research purposes only.